Cholesterol Support
Targeted cholesterol management program
Company profile
Company profile
Omada Health is a digital care program that uses AI and human coaching to help people with chronic conditions like diabetes and hypertension.
Company description Omada Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Launch of GLP-1 companion program (before, during, after medication lifecycle support), GLP-1 prescribing capabilities, GLP-1 Flex Care benefit design, targeted cholesterol support program, Horizon Day 2026 event planned for May 27, 2026
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Targeted cholesterol management program
Comprehensive GLP-1 medication lifecycle support program
AI-powered food tracking and nutrition guidance
GLP-1 medication prescribing capabilities within Omada platform
Virtual diabetes management program with CGM and specialist support
Virtual blood pressure management program beyond medications
Digital physical therapy for musculoskeletal pain relief
Virtual program for weight loss and prediabetes prevention
Integrated virtual care platform for chronic disease management
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Physical therapy · Jun 2, 2025
Transforming Hypertension Diagnosis and Management in The Era of Artificial Intelligence: A 2023 National Heart, Lung, and Blood Institute (NHLBI) Workshop Report.Hypertension (Dallas, Tex. : 1979) · Jan 1, 2025
A Proposed Decision-Making Framework for the Translation of In-Person Clinical Care to Digital Care: Tutorial.JMIR medical education · Jun 26, 2024
Modeling the economic value of cardiometabolic virtual-first care programs.The American journal of managed care · May 1, 2024
Implementation and evaluation of Exercise is Medicine in primary care clinics within a large academic health system.Family medicine and community health · Feb 2, 2024
Long-Term Results of a Digital Diabetes Self-Management and Education Support Program Among Adults With Type 2 Diabetes: A Retrospective Cohort Study.The science of diabetes self-management and care · Feb 1, 2024
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Cost savings for organizations
Cardiometabolic programs
Between care team and members
Individual health improvement through Omada program
Improved health outcomes (specific metrics not provided in excerpt)
Added Omada for Diabetes program to employee benefits
Described as 'no brainer' decision by Benefits & Compensations Analyst
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Omada Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.